                         SEQUENCE LISTING

<110>  Sanofi-Aventis Deutschland GmbH
 
<120>  Methods and uses relating to the identification of compound 
       involved in pain as well as methods of diagnosing algesia

<130>  DE2010/058 WO
<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  426
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Cys Asp Arg Asn Gly Gly Arg Arg Leu Arg Gln Trp Leu Ile Glu 
1               5                   10                  15      


Gln Ile Asp Ser Ser Met Tyr Pro Gly Leu Ile Trp Glu Asn Glu Glu 
            20                  25                  30          


Lys Ser Met Phe Arg Ile Pro Trp Lys His Ala Gly Lys Gln Asp Tyr 
        35                  40                  45              


Asn Gln Glu Val Asp Ala Ser Ile Phe Lys Ala Trp Ala Val Phe Lys 
    50                  55                  60                  


Gly Lys Phe Lys Glu Gly Asp Lys Ala Glu Pro Ala Thr Trp Lys Thr 
65                  70                  75                  80  


Arg Leu Arg Cys Ala Leu Asn Lys Ser Pro Asp Phe Glu Glu Val Thr 
                85                  90                  95      


Asp Arg Ser Gln Leu Asp Ile Ser Glu Pro Tyr Lys Val Tyr Arg Ile 
            100                 105                 110         


Val Pro Glu Glu Glu Gln Lys Cys Lys Leu Gly Val Ala Thr Ala Gly 
        115                 120                 125             


Cys Val Asn Glu Val Thr Glu Met Glu Cys Gly Arg Ser Glu Ile Asp 
    130                 135                 140                 


Glu Leu Ile Lys Glu Pro Ser Val Asp Asp Tyr Met Gly Met Ile Lys 
145                 150                 155                 160 


Arg Ser Pro Ser Pro Pro Glu Ala Cys Arg Ser Gln Leu Leu Pro Asp 
                165                 170                 175     


Trp Trp Ala Gln Gln Pro Ser Thr Gly Val Pro Leu Val Thr Gly Tyr 
            180                 185                 190         


Thr Thr Tyr Asp Ala His His Ser Ala Phe Ser Gln Met Val Ile Ser 
        195                 200                 205             


Phe Tyr Tyr Gly Gly Lys Leu Val Gly Gln Ala Thr Thr Thr Cys Pro 
    210                 215                 220                 


Glu Gly Cys Arg Leu Ser Leu Ser Gln Pro Gly Leu Pro Gly Thr Lys 
225                 230                 235                 240 


Leu Tyr Gly Pro Glu Gly Leu Glu Leu Val Arg Phe Pro Pro Ala Asp 
                245                 250                 255     


Ala Ile Pro Ser Glu Arg Gln Arg Gln Val Thr Arg Lys Leu Phe Gly 
            260                 265                 270         


His Leu Glu Arg Gly Val Leu Leu His Ser Ser Arg Gln Gly Val Phe 
        275                 280                 285             


Val Lys Arg Leu Cys Gln Gly Arg Val Phe Cys Ser Gly Asn Ala Val 
    290                 295                 300                 


Val Cys Lys Gly Arg Pro Asn Lys Leu Glu Arg Asp Glu Val Val Gln 
305                 310                 315                 320 


Val Phe Asp Thr Ser Gln Phe Phe Arg Glu Leu Gln Gln Phe Tyr Asn 
                325                 330                 335     


Ser Gln Gly Arg Leu Pro Asp Gly Arg Val Val Leu Cys Phe Gly Glu 
            340                 345                 350         


Glu Phe Pro Asp Met Ala Pro Leu Arg Ser Lys Leu Ile Leu Val Gln 
        355                 360                 365             


Ile Glu Gln Leu Tyr Val Arg Gln Leu Ala Glu Glu Ala Gly Lys Ser 
    370                 375                 380                 


Cys Gly Ala Gly Ser Val Met Gln Ala Pro Glu Glu Pro Pro Pro Asp 
385                 390                 395                 400 


Gln Val Phe Arg Met Phe Pro Asp Ile Cys Ala Ser His Gln Arg Ser 
                405                 410                 415     


Phe Phe Arg Glu Asn Gln Gln Ile Thr Val 
            420                 425     


